Markets / Retension Pharmaceuticals, Inc.

Retension Pharmaceuticals, Inc.

Strongly bullish

Technical analysis · daily indicators as of Nov 19, 2026

13.01
-0.88 (-6.34%)

In short

Retension Pharmaceuticals has fallen 13.3% in a month and is 30% below its 52-week high, after its results on 18 Nov (the share rose 21.7% on the day it reacted).

Price chart

Drag to measure a move, wheel or pinch to zoom

The verdict

The main signals
    1-year return
    +23.6%
    Industry -33.8% · S&P 500 +8.4%
    Daily price swing
    13.3%
    Calm 2.2%Wild 8.7%
    Beta vs S&P 500
    –
    Not enough history
    Dividend yield
    –
    Not known

    Returns against the market

    Last 7 days
    Retension Pharmaceuticals
    +6.2%Industry
    -8.1%S&P 500
    -5.5%
    Last year
    Retension Pharmaceuticals
    +23.6%Industry
    -33.8%S&P 500
    +8.4%

    Beat its industry (pharmaceutical preparations) and beat the S&P 500 over the past year. Industry = the middle stock of the same SEC industry. Price returns, dividends not added back.

    Price history $13.01 today

    52-week low $9.66high $18.64
    1 month-13.3%
    1 year+23.6%
    Since 2026+23.6%

    Who owns and trades it

    InsidersNo open-market buys or sales in the last 12 months.Every insider trade ›

    None of the big investors we follow holds it. Big investors ›

    About Retension Pharmaceuticals

    Pharmaceutical PreparationsNasdaqTicker RTSN

    Momentum

    RSI (14)
    57.8Neutral
    Stochastic %K
    68.5Neutral
    ADX (14)
    25.9Strong trend

    Trend

    Price vs SMA 20
    12.33Above
    Supertrend
    8.77Bullish

    Volatility & volume

    Moving averages

    PeriodSMAEMA

    Crossovers

    Candlestick patterns

    On the last daily candle

    Activity

    Frequently asked questions

    Is Retension Pharmaceuticals, Inc. bullish or bearish today?

    Based on 3 common daily signals, Retension Pharmaceuticals, Inc.'s technical rating is "Strongly bullish". This is information only, not a recommendation.

    What is the RSI of RTSN?

    RTSN's 14-day RSI is 57.8 as of the 2026-11-19 close. Below 30 is usually called oversold and above 70 overbought.

    What is Retension Pharmaceuticals, Inc.'s market cap and P/E?

    Market cap $116 million, from today's price and the last 12 months of results filed with the SEC.

    Technical ratings summarise common indicators for information only. They are not buy or sell recommendations.

    How to read this page

    The snapshot at the top sums up the company: its price, valuation and a score from 20 checks on four sides (value, past performance, financial health and dividends), with how the company compares with others in its industry. The chart shows the price with moving averages; the technical readings below (RSI, MACD, support and resistance) describe the trend and momentum.

    The Fundamentals tab has the results from the company's SEC filings: revenue, profit, margins and growth, quarter by quarter. Foreign companies that report only once a year show yearly figures, converted to US dollars when they report in another currency. Use the results and filings to check whether a move is backed by the business.

    New to this? Read the guideHow to read a candlestick chart7 min read

    Related tools

    All US tools →